New application of a kind of pharmaceutical composition and its preparation

A composition and drug technology, which can be used in drug combinations, pharmaceutical formulations, anti-tumor drugs, etc., can solve the problems of delayed patient treatment time, inconvenient treatment of patients, and inability to exert drug effects well.
CN105030948BActive Publication Date: 2019-05-17陕西郝其军制药股份有限公司
5 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
陕西郝其军制药股份有限公司
Publication Date
2019-05-17

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a drug combination and application of a preparation of the drug combination to the fields of preparing drugs for treating chronic granulocytic leukemia, polycythemia vera and primary thrombocytosis. The drug combination is formed through compatibility of natural indigo, tree peony bark, fructus forsythiae, hairyvein agrimony and liquorice, and has remarkable effects of treating the chronic granulocytic leukemia, the polycythemia vera and the primary thrombocytosis.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to the application of a pharmaceutical composition and its preparation in the field of preparing medicines for treating chronic myeloid leukemia, polycythemia vera and essential thrombocythemia. Background technique

[0002] Chronic myelogenous leukemia, referred to as CML for short, is a cell line disease caused by malignant lesions at the level of pluripotent stem cells with acquired chromosomal abnormalities. Mature white blood cells gather in the bone marrow, inhibit the normal hematopoiesis of the bone marrow, and can spread throughout the body through the blood, leading to anemia, easy bleeding, infection, and organ infiltration in patients. The cause of the disease is still unclear, but it is believed that the Philadelphia chromosome is closely related to the disease, and about 90 to 95% of patients have the Philadelphia chromosome. Chronic myelogenous ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More